What do Analysts Say about Karyopharm Therapeutics Inc.(NASDAQ:KPTI): Delphi Technologies PLC(NYSE:DLPH)

0
2

Karyopharm Therapeutics Inc. (KPTI) will report its next earnings on Nov 04 BMO. The company reported the earnings of $-0.67/Share in the last quarter where the estimated EPS by analysts was $-0.83/share. The difference between the expected and actual EPS was $0.16/share, which represents an Earnings surprise of 19.3%.

Many analysts are providing their Estimated Earnings analysis for Karyopharm Therapeutics Inc. and for the current quarter 8 analysts have projected that the stock could give an Average Earnings estimate of $-0.68/share. These analysts have also projected a Low Estimate of $-0.82/share and a High Estimate of $-0.61/share.

In case of Revenue Estimates, 8 analysts have provided their consensus Average Revenue Estimates for Karyopharm Therapeutics Inc. as 15.65 Million. According to these analysts, the Low Revenue Estimate for Karyopharm Therapeutics Inc. is 12 Million and the High Revenue Estimate is 19.3 Million. The company had Year Ago Sales of 206 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for KPTI to be 30.2%. They are projecting Next Quarter growth of 45.87%. For the next 5 years, Karyopharm Therapeutics Inc. is expecting Growth of 35.51% per annum, whereas in the past 5 years the growth was 0.32% per annum.

Some buy side analysts are also providing their Analysis on Karyopharm Therapeutics Inc., where 3 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Karyopharm Therapeutics Inc. might touch $36 high while the Average Price Target and Low price Target is $23.25 and $17 respectively.

Karyopharm Therapeutics Inc. closed its last trading session at $15.6 with the gain of 3.94%. The Market Capitalization of the company stands at 1 Billion. The Company has 52-week high of $15.80 and 52-week low of $3.92. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 19.86% where SMA50 and SMA200 are 38.72% and 105.66% respectively. The Company Touched its 52-Week High on 11/20/19 and 52-Week Low on 03/01/19.

The Relative Volume of the company is 0.71 and Average Volume (3 months) is 1.59 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -71.9%. The Return on Equity (ROE) value stands at -187.2%. While it’s Return on Investment (ROI) value is -62.9%.

While looking at the Stock’s Performance, Karyopharm Therapeutics Inc. currently shows a Weekly Performance of 7.46%, where Monthly Performance is 42.61%, Quarterly performance is 77.02%, 6 Months performance is 165.82% and yearly performance percentage is 51.83%. Year to Date performance value (YTD perf) value is 73.05%. The Stock currently has a Weekly Volatility of 3.50% and Monthly Volatility of 4.94%.

Delphi Technologies PLC (DLPH) will report its next earnings on Oct 31 BMO. The company reported the earnings of $0.56/Share in the last quarter where the estimated EPS by analysts was $0.56/share. The difference between the expected and actual EPS was $0/share, which represents an Earnings surprise of 0%.

Many analysts are providing their Estimated Earnings analysis for Delphi Technologies PLC and for the current quarter 14 analysts have projected that the stock could give an Average Earnings estimate of $0.51/share. These analysts have also projected a Low Estimate of $0.43/share and a High Estimate of $0.82/share.

In case of Revenue Estimates, 14 analysts have provided their consensus Average Revenue Estimates for Delphi Technologies PLC as 1.01 Billion. According to these analysts, the Low Revenue Estimate for Delphi Technologies PLC is 998.1 Million and the High Revenue Estimate is 1.04 Billion. The company had Year Ago Sales of 1.17 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for DLPH to be -45.3%. They are projecting Next Quarter growth of 1.49%. For the next 5 years, Delphi Technologies PLC is expecting Growth of 2.49% per annum, whereas in the past 5 years the growth was -46.35% per annum.

Some buy side analysts are also providing their Analysis on Delphi Technologies PLC, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 5 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Delphi Technologies PLC might touch $20 high while the Average Price Target and Low price Target is $15.36 and $13 respectively.

Delphi Technologies PLC closed its last trading session at $11.74 with the loss of -3.75%. The Market Capitalization of the company stands at 974.29 Million. The Company has 52-week high of $26.82 and 52-week low of $11.17. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -13.36% where SMA50 and SMA200 are -17.24% and -35.63% respectively. The Company Touched its 52-Week High on 04/18/19 and 52-Week Low on 11/18/19.

The Relative Volume of the company is 0.81 and Average Volume (3 months) is 1.56 million. The company’s P/E (price to earnings) ratio is 5.26 and Forward P/E ratio of 4.9.

The company shows its Return on Assets (ROA) value of 5%. The Return on Equity (ROE) value stands at 56.4%. While it’s Return on Investment (ROI) value is 24.4%.

While looking at the Stock’s Performance, Delphi Technologies PLC currently shows a Weekly Performance of -8.13%, where Monthly Performance is -21.25%, Quarterly performance is -17.94%, 6 Months performance is -34.3% and yearly performance percentage is -33.29%. Year to Date performance value (YTD perf) value is -21.09%. The Stock currently has a Weekly Volatility of 5.63% and Monthly Volatility of 5.87%.

SHARE